A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
Clinical trial NCT02146079 · COMPLETED
Trial details
- NCT number
- NCT02146079
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-21
- Primary completion
- 2014-10-20
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.